{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:17:48Z","timestamp":1785799068119,"version":"3.56.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["NO. 81460560"],"award-info":[{"award-number":["NO. 81460560"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["NO. 81960664"],"award-info":[{"award-number":["NO. 81960664"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Applied Basic Research Program of Yunnan Province of China","award":["NO. 2017FB134"],"award-info":[{"award-number":["NO. 2017FB134"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s10072-019-04213-7","type":"journal-article","created":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T18:02:21Z","timestamp":1578420141000},"page":"1041-1049","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The associations of HLA-DRB1 gene polymorphisms with late-onset myasthenia gravis: a meta-analysis"],"prefix":"10.1007","volume":"41","author":[{"given":"Cai-Se","family":"Ling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Li","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Ke","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Qian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2525-6083","authenticated-orcid":false,"given":"Gong-Hao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,7]]},"reference":[{"key":"4213_CR1","doi-asserted-by":"crossref","unstructured":"Chen L , Xie W , Zheng D , et al.\u00a0 Early extubation after thymectomy is good for the patients with myasthenia gravis[J].Neurological Sciences, 2019, 40(10):2125\u20132132","DOI":"10.1007\/s10072-019-03941-0"},{"issue":"5","key":"4213_CR2","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrneurol.2016.44","volume":"12","author":"NE Gilhus","year":"2016","unstructured":"Gilhus NE, Skeie GO, Romi F, Lazaridis K, Zisimopoulou P, Tzartos S (2016) Myasthenia gravis\u2014autoantibody characteristics and their implications for therapy[J]. Nat Rev Neurol 12(5):259\u2013268","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"4213_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2017.04.002","volume":"27","author":"E Santos","year":"2017","unstructured":"Santos E, Bettencourt A, Da SA et al (2017) HLA and age of onset in myasthenia gravis[J]. Neuromuscul Disord 27(7):S0960896617300603","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"4213_CR4","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","volume":"8","author":"MN Meriggioli","year":"2009","unstructured":"Meriggioli MN, Sanders DB (2009) Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity[J]. Lancet Neurol 8(5):475\u2013490","journal-title":"Lancet Neurol"},{"issue":"6","key":"4213_CR5","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1212\/01.wnl.0000176067.32186.a3","volume":"65","author":"FE Somnier","year":"2005","unstructured":"Somnier FE (2005) Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis[J]. Neurology 65(6):928\u2013930","journal-title":"Neurology"},{"issue":"12","key":"4213_CR6","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1007\/s00415-010-5651-z","volume":"257","author":"I Casetta","year":"2010","unstructured":"Casetta I, Groppo E, Gennaro RD et al (2010) Myasthenia gravis: a changing pattern of incidence[J]. J Neurol 257(12):2015\u20132019","journal-title":"J Neurol"},{"issue":"4","key":"4213_CR7","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1159\/000328863","volume":"36","author":"F Pallaver","year":"2011","unstructured":"Pallaver F, Riviera AP, Piffer S, Ricciardi R, Roni R, Orrico D, Bonifati DM (2011) Change in myasthenia gravis epidemiology in Trento, Italy, after twenty years. Neuroepidemiology 36(4):282\u2013287","journal-title":"Neuroepidemiology"},{"issue":"10","key":"4213_CR8","doi-asserted-by":"publisher","first-page":"e0186383","DOI":"10.1371\/journal.pone.0186383","volume":"12","author":"TH Popperud","year":"2017","unstructured":"Popperud TH, Viken MK, Kerty E et al (2017) Juvenile myasthenia gravis in Norway: HLA-DRB1*04:04 is positively associated with prepubertal onset.[J]. Plos One 12(10):e0186383","journal-title":"Plos One"},{"key":"4213_CR9","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jaut.2013.12.001","volume":"52","author":"N Avidan","year":"2014","unstructured":"Avidan N, Le PR, Berrih-Aknin S et al (2014) Genetic basis of myasthenia gravis - a comprehensive review[J]. J Autoimmun 52:146\u2013153","journal-title":"J Autoimmun"},{"key":"4213_CR10","unstructured":"Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojyobori T (1992) Allele and haplotype frequencies for HLA and complement loci in various ethnic group, HLA 1991. Oxford: Oxford Press 1:1063\u20131220"},{"issue":"1","key":"4213_CR11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jneuroim.2010.10.023","volume":"230","author":"S Suzuki","year":"2011","unstructured":"Suzuki S, Utsugisawa K, Nagane Y et al (2011) Clinical and immunological differences between early and late-onset myasthenia gravis in Japan[J]. J Neuroimmunol 230(1):148\u2013152","journal-title":"J Neuroimmunol"},{"issue":"11","key":"4213_CR12","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.jocn.2011.05.002","volume":"18","author":"YC Xie","year":"2011","unstructured":"Xie YC, Qu Y, Sun L et al (2011) Association between HLA-DRB1 and myasthenia gravis in a northern Han Chinese population[J]. J Clin Neurosci 18(11):1527","journal-title":"J Clin Neurosci"},{"issue":"1","key":"4213_CR13","first-page":"541760","volume":"2012","author":"M Testi","year":"2012","unstructured":"Testi M, Terracciano C, Guagnano A et al (2012) Association of HLA-DQB1*05:02 and DRB1*16 alleles with late-onset, nonthymomatous, AChR-Ab-positive myasthenia gravis[J]. Autoimmune Dis 2012(1):541760","journal-title":"Autoimmune Dis"},{"issue":"1\u20132","key":"4213_CR14","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jns.2015.11.021","volume":"359","author":"S Ehsan","year":"2015","unstructured":"Ehsan S, Amirzargar A, Yekaninejad MS, Mahmoudi M, Mehravar S, Moradi B, Nafissi S (2015) Association of HLA class II (DRB1, DQA1, DQB1) alleles and haplotypes with myasthenia gravis and its subgroups in the Iranian population[J]. J Neurol Sci 359(1\u20132):335\u2013342","journal-title":"J Neurol Sci"},{"issue":"1","key":"4213_CR15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1749-6632.1998.tb10946.x","volume":"841","author":"F Baggi","year":"2010","unstructured":"Baggi F, Antozzi C, Andreetta F et al (2010) Identification of a novel HLA class II association with DQB1*0502 in an Italian myasthenic population.[J]. Ann N Y Acad Sci 841(1):355\u2013359","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"4213_CR16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.clineuro.2012.04.001","volume":"115","author":"N Fekihmrissa","year":"2013","unstructured":"Fekihmrissa N, Klai S, Zaouali J et al (2013) Association of HLA-DR\/DQ polymorphism with myasthenia gravis in Tunisian patients.[J]. Clin Neurol Neurosurg 115(1):32\u201336","journal-title":"Clin Neurol Neurosurg"},{"key":"4213_CR17","doi-asserted-by":"publisher","first-page":"e36603","DOI":"10.1371\/journal.pone.0036603","volume":"7","author":"AH Maniaol","year":"2012","unstructured":"Maniaol AH, Elsais A, Lorentzen \u00c5R et al (2012) Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population[J]. PLoS One 7:e36603","journal-title":"PLoS One"},{"issue":"1","key":"4213_CR18","doi-asserted-by":"publisher","first-page":"769","DOI":"10.2119\/molmed.2015.00232","volume":"21","author":"MF Seldin","year":"2015","unstructured":"Seldin MF, Alkhairy OK, Lee AT et al (2015) Genome-wide association study of late-onset myasthenia gravis: confirmation of TNFRSF11A, and identification of ZBTB10 and three distinct HLA associations[J]. Mol Med 21(1):769\u2013781","journal-title":"Mol Med"},{"key":"4213_CR19","doi-asserted-by":"crossref","unstructured":"Hui-yu F , Li-xuan Y , Wei-bin L , Xin H., Li Q , Yan L.The HLA-B*4601-DRB1*0901 haplotype is positively correlated with juvenile ocular myasthenia gravis in a southern Chinese Han population[J]. Neurological Sciences, 2015, 36(7):1135\u20131140","DOI":"10.1007\/s10072-015-2235-9"},{"key":"4213_CR20","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1007\/s00415-019-09225-z","volume":"266","author":"R Massa","year":"2019","unstructured":"Massa R, Greco G, Testi M et al (2019) Thymomatous myasthenia gravis: novel association with HLA DQB1*05:01 and strengthened evidence of high clinical and serological severity[J]. J Neurol 266:982\u2013989","journal-title":"J Neurol"},{"issue":"9","key":"4213_CR21","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses[J]. Eur J Epidemiol 25(9):603\u2013605","journal-title":"Eur J Epidemiol"},{"issue":"7","key":"4213_CR22","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/j.1538-7836.2012.04756.x","volume":"10","author":"J Reny","year":"2012","unstructured":"Reny J, Combescure C, Daali Y, Fontana P, PON1 Meta-Analysis Group (2012) Influence of the paraoxonase-1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta-analysis. J Thromb Haemost 10(7):1242\u20131251","journal-title":"J Thromb Haemost"},{"key":"4213_CR23","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/brain\/103.3.579","volume":"103","author":"DA Compston","year":"1980","unstructured":"Compston DA, Vincent A, Newsom-Davis J, Batchelor JR (1980) Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain 103:579\u2013601","journal-title":"Brain"},{"key":"4213_CR24","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1111\/j.1532-5415.2000.tb02635.x","volume":"48","author":"A Evoli","year":"2000","unstructured":"Evoli A, Batocchi AP, Minisci C, Di Schino C, Tonali P (2000) Clinical characteristics and prognosis of myasthenia gravis in older people. J Am Geriatr Soc 48:1442\u20131448","journal-title":"J Am Geriatr Soc"},{"key":"4213_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0106757","volume":"9","author":"T Akaishi","year":"2014","unstructured":"Akaishi T et al (2014) Insights into the classification of myasthenia gravis. PLoS One 9:e106757","journal-title":"PLoS One"},{"key":"4213_CR26","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/S0198-8859(99)00062-2","volume":"60","author":"M Janer","year":"1999","unstructured":"Janer M, Cowland A, Picard J, Campbell D, Pontarotti P, Newsom-Davis J, Bunce M, Welsh K, Demaine A, Wilson AG, Willcox N (1999) A susceptibility region for myasthenia gravis extending into the HLA-class I sector telomeric to HLA-C. Hum Immunol 60:909\u2013917","journal-title":"Hum Immunol"},{"key":"4213_CR27","doi-asserted-by":"crossref","unstructured":"Tremolizzo L, Giopato F, Piatti ML, Rigamonti A, Ferrarese C, Appollonio I.Myasthenia gravis mimicking stroke: a case series with sudden onset dysarthria[J]. Neurological Sciences, 2015, 36(6):895\u2013898","DOI":"10.1007\/s10072-015-2098-0"},{"issue":"9","key":"4213_CR28","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1212\/WNL.57.9.1555","volume":"57","author":"M Giraud","year":"2001","unstructured":"Giraud M, Beaurain G, Yamamoto AM, Eymard B, Tranchant C, Gajdos P, Garchon HJ (2001) Linkage of HLA to myasthenia gravis and genetic heterogeneity depending on anti-titin antibodies[J]. Neurology 57(9):1555\u20131560","journal-title":"Neurology"},{"issue":"11","key":"4213_CR29","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1001\/archneur.57.11.1596","volume":"57","author":"F Romi","year":"2000","unstructured":"Romi F, Skeie GO, Aarli JA, Gilhus NE (2000) The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies[J]. Arch Neurol 57(11):1596\u20131600","journal-title":"Arch Neurol"},{"issue":"6","key":"4213_CR30","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1001\/archneur.58.6.885","volume":"58","author":"AM Yamamoto","year":"2001","unstructured":"Yamamoto AM, Gajdos P, Eymard B, Tranchant C, Warter JM, Gomez L, Bourquin C, Bach JF, Garchon HJ (2001) Anti-titin antibodies in myasthenia gravis: tight association with thymoma and heterogeneity of nonthymoma patients[J]. Arch Neurol 58(6):885\u2013890","journal-title":"Arch Neurol"},{"issue":"8","key":"4213_CR31","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/archneur.64.8.1121","volume":"64","author":"S Suzuki","year":"2007","unstructured":"Suzuki S, Utsugisawa K, Nagane Y, Satoh T, Terayama Y, Suzuki N, Kuwana M (2007) Classification of myasthenia gravis based on autoantibody status[J]. Arch Neurol 64(8):1121\u20131124","journal-title":"Arch Neurol"},{"issue":"1","key":"4213_CR32","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1196\/annals.1254.062","volume":"998","author":"F Romi","year":"2010","unstructured":"Romi F, Gilhus NE, Varhaug JE et al (2010) Thymectomy and antimuscle antibodies in nonthymomatous myasthenia gravis.[J]. Ann N Y Acad Sci 998(1):481\u2013490","journal-title":"Ann N Y Acad Sci"},{"key":"4213_CR33","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s10072-019-03746-1","volume":"40","author":"A Evoli","year":"2019","unstructured":"Evoli A, Antonini G, Antozzi C et al (2019) Italian recommendations for the diagnosis and treatment of myasthenia gravis[J]. Neurol Sci 40:1111\u20131124","journal-title":"Neurol Sci"},{"key":"4213_CR34","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1080\/08820139.2018.1493498","volume":"48","author":"H Abdelhafidh","year":"2019","unstructured":"Abdelhafidh H, Almawi Wassim Y, Mouna S et al (2019) Association of HLA-DRB1 and -DQB1 alleles with type 1 (autoimmune) diabetes in African Arabs: systematic review and meta-analysis.[J]. Immunol Investig 48:130\u2013146","journal-title":"Immunol Investig"},{"key":"4213_CR35","doi-asserted-by":"crossref","unstructured":"Hong Y, Li HF, Romi F et al (2018) HLA and MuSK-positive myasthenia gravis: a systemic review and meta-analysis.[J]. Acta Neurol Scand:138(3)","DOI":"10.1111\/ane.12951"},{"issue":"5","key":"4213_CR36","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.coi.2012.07.013","volume":"24","author":"BF Voight","year":"2012","unstructured":"Voight BF, Cotsapas C (2012) Human genetics offers an emerging picture of common pathways and mechanisms in autoimmunity [J]. Curr Opin Immunol 24(5):552\u2013557","journal-title":"Curr Opin Immunol"},{"issue":"9","key":"4213_CR37","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nrg3502","volume":"14","author":"M Parkes","year":"2013","unstructured":"Parkes M, Cortes A, Heel DAV et al (2013) Genetic insights into common pathways and complex relationships among immune-mediated diseases[J]. Nat Rev Genet 14(9):661\u2013673","journal-title":"Nat Rev Genet"},{"issue":"1","key":"4213_CR38","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s12253-011-9415-6","volume":"18","author":"M Mahmoodi","year":"2012","unstructured":"Mahmoodi M, Nahvi H, Mahmoudi M, Kasaian A, Mohagheghi MA, Divsalar K, Nahavandian B, Jafari A, Ansarpour B, Moradi B, Aghamohammadi A, Amirzargar A (2012) HLA-DRB1,-DQA1 and -DQB1 allele and haplotype frequencies in female patients with early onset breast cancer[J]. Pathology & Oncology Research 18(1):49\u201355","journal-title":"Pathology & Oncology Research"},{"issue":"1","key":"4213_CR39","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1086\/380997","volume":"74","author":"JR Oksenberg","year":"2004","unstructured":"Oksenberg JR, Barcellos LF, Cree BA, Baranzini SE, Bugawan TL, Khan O, Lincoln RR, Swerdlin A, Mignot E, Lin L, Goodin D, Erlich HA, Schmidt S, Thomson G, Reich DE, Pericak-Vance MA, Haines JL, Hauser SL (2004) Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans.[J]. Am J Hum Genet 74(1):160\u2013167","journal-title":"Am J Hum Genet"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-019-04213-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-019-04213-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-019-04213-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T20:43:06Z","timestamp":1695588186000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-019-04213-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,7]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["4213"],"URL":"https:\/\/doi.org\/10.1007\/s10072-019-04213-7","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,7]]},"assertion":[{"value":"3 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All results and analyses were based on previous ethically-approved studies, thus no further ethical approval and patient consent are required.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}